Patients with amyotrophic lateral sclerosis have limited treatment options and a 20% survival rate within five years of diagnosis. Small animal models show promise for halting the associated neurodegeneration when cellular therapeutics are delivered to the ventral horn of the spinal cord. A template-based guidance system was developed to facilitate percutaneous injections under MRI guidance to improve upon existing invasive and time-consuming surgical techniques. Procedure duration was 30 min plus 5 min per insertion, with a mean error of < 2 mm.
Introduction
Amyotrophic lateral sclerosis (ALS) is a devastating disease with roughly 80% of patients succumbing to it within five years [1, 2] . Symptoms are due to the progressive degeneration of motor neurons. ALS research in small animal models has shown evidence of axonal regeneration, neural protection, and re-myelination when cells are injected in the ventral horn of the spinal cord near the cervical enlargement [3] [4] [5] [6] [7] . These results have encouraged recent human and large animal studies where stem cells are directly injected into the spinal cord. Direct injection cell delivery to the spinal cord parenchyma allows visual confirmation of success, and does not rely on cells migrating to the therapy area [8] [9] [10] [11] . Currently, direct injection methods require a multi-level laminectomy and dissection of the dura mater to expose the cord for cell infusion. This approach is acceptable for small trials with patients in the final stages of the disease, but an open surgical approach to direct injection is ultimately undesirable for the field to progress.
Continuous development of hardware and software in the realm of MRI-guided interventions has provided new ways to exploit the excellent soft tissue contrast, high spatial resolution, and multi-planar imaging capabilities of MRI. The development of imaging-based interventional needle targeting and positioning systems for commercial applications and research settings has been undertaken by numerous sources. Perfint Robio/Maxio, Brainlab Varioguide/iPlan, Stryker Nav3, Innomotion, Accubot, NeuroArm, and Steady Hand are a representative sample of such systems [12] [13] [14] [15] . The majority of these systems are used in conjunction with CT (computed tomography) or US (ultrasound), which enable high accessibility to the patient, good needle visualization [16] , as well as minimal restrictions on materials. For this study's ultimate goal of delivering cellular therapeutics to the spinal cord, MRI was mandated as the imaging modality for treatment guidance because the specific anatomical locations can only be visualized with MRI. The ventral gray matter horn within the spinal cord is the target for ALS studies performed by the research group, and MRI is required to visualize the contrast between gray and white matter. Similar targeting requirements are necessary to visualize injury or inflammation sites present in patients with ALS. Thus, the plethora of systems which have been developed for CT and US do not meet the requirements of the research group. There are few systems which have been adapted for use within the MRI scanner. The Steady Hand system from John's Hopkins has been used for prostate interventions but has not been adapted to neurologic applications [17, 18] . Studies have been reported for MRI-guided interventions using the Innomotion and NeuroArm systems [19] [20] [21] [22] . However both designs are complex and of a large size which takes up the limited space in the MRI bore, requiring a sufficient amount of setup time. Existing template-based systems, such as the in vivo grid localization system as well as the HDR prostate template by SeeDOS, provide a simple mechanism but lack the physical size and angulation capabilities necessary for percutaneous targeting of the spinal cord.
Our device, SpinoTemplate, percutaneously injects therapeutics under MRI guidance into the spinal cord, allowing accurate and minimally invasive administration of spinal treatments. The major contribution of this work is enhancing the positioning of the therapeutic injection via an MRI-guided template-based platform with minimal adjustments to the positioning of the device once on the patient. The template-based guidance enables a simplified workflow for trajectory planning, percutaneous spinal access, therapeutics injections, and subsequent imaging validation, thereby reducing planning time and improving targeting accuracy at the spinal cord. This study examines the accuracy and workflow of MRIguided cellular therapeutics injections using SpinoTemplate, a targeting and injection needle guidance system.
Methods

SpinoTemplate design
The design of the SpinoTemplate resulted from meeting the requirements of the surgeons who operate the device as well as the MRI interventional radiologists in our team. Their requirements included:
. Fabrication from MR-safe materials, preferably those which do not create image distortion in MR images in order to maintain good MR image quality. . A needle injection (cannula and stylet) must be guided and inserted through the gaps between vertebrae into the spinal cord ( Fig. 1 ) so that the procedure can be performed percutaneously, i.e. minimally invasive.
. A 16-gauge cannula is necessary to allow a needle from a microinjection system to be used, as well as ensuring sufficient strength and stiffness to pierce muscle and lamina. . Needle insertions are performed by hand in order to obtain realistic force feedback. . A design capable of performing multiple insertions along an approximately 10 cm length of the spinal cord without adjusting fixation to the patient, which reduces procedure time. . The method of attachment to the surgical structure must be as minimally invasive as feasible, furthering the dissociation from invasive procedures. . The design shall be simple to operate and must be disposable or able to be sterilized for future in vivo trials.
A template-based positioning and guidance system was determined to be the most efficient way of meeting these requirements ( Fig. 2(a) ). The positioner consists of two primary components: the template and the support structure. In order to maintain MRI safety and compatibility, all hardware is fabricated from nonmetallic and nonmagnetizable materials, primarily polyoxymethylene. The support structure serves two purposes: positioning the template and attaching to the patient. The template guides the needle used for cell injection. The support structure contains holes through which pins can be inserted into the template in order to stabilize it at a certain angle. Angles are available in discrete steps of 5 between À45 and 45 , with 0 being the flat, baseline position. Although a smaller step angle would be ideal, the 5 step was chosen to ensure structural rigidity of the support frame and ensure the pins were of sufficient diameter to not shear if a surgeon applied a large amount of force. The pinning method places all control in the hands of the surgeon, eliminating control and power lines needed for robotic approaches. In combination with the ability to insert a needle to any depth, constrained only by the length of the needle, the guidance system combines aspects of both continuous and discrete workspaces. Within certain transverse planes, the combination of set insertion points along a row in the template with pinning rotation at discrete angles generate a pattern of potential insertion paths which approach continuous coverage at the likely depths of the spinal cord (Fig. 2) .
The positioner is designed to attach to subjects via a neoprene wrap. The neoprene wrap surrounds the body holding the frame tight to the back. The neoprene is removed within the workspace of the template so that the skin is accessible. Current open surgical frames for stereotactic targeting use pedicle screws to attach the frame to the bone structure. The current template positioner provides a less invasive method of affixation. A cause of movement error is respiratory motion in in vivo studies [24] ; this could be mitigated by momentarily pausing the intubation system during needle insertions. A short T2-weighted scan is taken immediately after a needle insertion to confirm the targeting position. Should relative movement between the skin and spine prove problematic, a pedicle screw fixation system is available [25, 26] .
The positioner is designed to attach to patients via a neoprene wrap and sutures. Neoprene is removed within the workspace of the template so that the skin is accessible. The frame is designed to allow the positioner to be sutured to the body, providing a less invasive method of affixation than pedicle screws. Should relative movement between the skin and spine prove problematic, a pedicle screw fixation system used in similar studies is available. For ex vivo trials, an acrylic box and a support structure were substituted in order to contain fluids draining from the subject.
The choice of a template was driven by the need to accurately guide a needle and target as many potential points as possible. The holes in the template are sized to fit a 16 gauge needle. Based on the diameter of the needle, a grid spacing of 3 mm was chosen for the holes in the template (Fig. 2(b) ), which maintains a good balance between the mechanical strength and rigidity of the template and the targeting resolution. The grid of holes spans a distance of approximately 10 cm by 11 cm, allowing multiple injections along the spinal cord without needing to adjust the attachments of the positioner.
Five wells are embedded in the template. The four located in the corners are used for registration of the positioner to MRI coordinates ( Fig. 2(c) ). The fifth well is positioned so that the identities of the registration wells are immediately apparent on the MR images. Fiducial markers (Beekley r PinPoints, $6 mm diameter spheres) appear as bright points on a dark background on the MR images. By entering the coordinates of the center of the markers into custom trajectory calculation software (programmed in LabView TM ), the positioner can be registered to the MR coordinate system. Registration is done with the template at the 0 position. A transformation matrix M is determined by comparing the MRI coordinates of the fiducial markers to the known positions of the fiducials in the template coordinate system. The target point P MRI in the MRI coordinate system is then transformed into P Template , the target in the template coordinate system, using M. Targeting equations then give the proper settings (row, column, depth) based on the target's point in the template coordinates and the desired insertion angle. The user is informed if a target is outside of the targetable volume. After registration has been successfully accomplished, users can select the angle at which to position the template. A target point is selected, and the trajectory calculation software provides the hole (in the form of a numerical row and alphabetical column) on the template and the length of the needle which will provide the most accurate targeting result, based on the template's angle. It is also possible to dictate the angle, based on the target point and a point along the needle's trajectory. Diagrams for axes definition and targeting calculations are shown in Fig. 3(c) ; below are calculations for template row and column, as well as insertion depth. When a target point cannot be reached, the user is informed along which axis or axes the targeting solution fails, allowing adjustment of the targeting angle to potentially bring the target into the workspace. Resulting theoretical error (assuming a perfectly straight insertion) is displayed to the user who determines if it is acceptable.
Column ¼ round
Insertion Depth ¼ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi
Theoretical insertion error is always 0 mm, since the insertion axis is continuous. Theoretical radial error is dependent on the target, with error calculated according to the following formulas. These formulas assume that the target point lies within the template workspace.
Workflow
Several trials were spent optimizing the workflow of the procedure to successfully advance the needle to reach the target in geometric phantoms and ex vivo swine spines. The workflow is listed below.
(1) SpinoTemplate was mounted above the subject, via support blocks and Velcro for phantom trials and excised ex vivo samples, and a neoprene wrap and for other ex vivo samples. An MR surface coil was laid over the platform and subject. (2) High-resolution images of the spine (Figs. 4(e)-4(g) ) and fiducial markers (Fig. 2(c) ) embedded in the platform were made using a 3D, magnetization-prepared, T1-weighted (T1w) fast gradient echo sequence (MP RAGE). (3) The images were analyzed to determine an acceptable intra-laminar gap through which the needle would be inserted in order to reach the target point. The target point and desired angle were entered into the targeting software, which reports the necessary settings on the platform and needle. The template angle was then adjusted to match the desired trajectory and the proper template hole was identified. (4) The 16 gauge rigid outer cannula with a rigid central stylet was advanced manually. The stylet was removed and gadolinium injected through the cannula. Alternately, a solid brass needle was inserted. (5) The needle was extracted and a T2*-weighted gradient echo sequence confirmed the location of the needle tract for gadolinium injections. For brass needle trials, the needle was kept in the subject during imaging and the artifact used to identify the needle trajectory. (6) Steps 3-5 are repeated for each insertion.
Targeting accuracy, as the distance between the target and the injection location in the spinal cord, was measured on the images.
Validation of targeting accuracy
Geometric Phantom Study: Preliminary tests (n ¼ 30) to validate the accuracy of the system were carried out using a geometric phantom. The phantom was a 3D-printed array of pyramid structures using ABS thermoplastic (acrylonitrile butadiene styrene). The pyramids were visualized clearly as image voids when submerged in a solidified agar bath (Fig. 4(b) ). Utilizing the peaks of pyramids as targets for needle insertions, the needle tip and trajectory were compared to the target point, generating measures of axial and transverse error from the MR images.
To quantify results, the template was mounted on the phantom: a glass container over plastic pyramids embedded in an agar gel (Fig. 4(a) ). Gadolinium (Gd) contrast agent was injected for trajectory and target visualization. After targeting scans and registering the template using attached fiducial markers, the correct hole and needle length were calculated for the desired target point. A needle stop was placed to fix the insertion depth. After inserting the needle, the stylet was removed and gadolinium injected. Using confirmation scans, axial error (along needle) and transverse error (in the plane perpendicular to needle) were calculated based on the distance between the visualized trajectory and the tip of the target pyramid. Axial error was measured along the central axis of the needle trajectory while the transverse error was measured perpendicular to the visualized trajectory. Total error is calculated as the hypotenuse of the axial and transverse errors. Swine Cadaver Study: Subsequent tests were performed on lumbar sections of fully grown swine spine and muscle (n ¼ 5) (Fig. 3) and full-bodied euthanized piglets (n ¼ 3) (Fig. 4) . The same procedure was used in the ex vivo swine trials as the phantom trials. In certain ex vivo swine samples, a solid brass needle was used in place of a gadolinium solution to determine the accuracy of the needle placement. The brass rod created a clearly defined void in the image with minimal artifacts, allowing it to be precisely located in confirmation scans. Figure 3 shows the needle targeting workspace of the SpinoTemplate. Within the transverse planes aligning with the template (Fig. 3(a) ), the design of the template creates a high density of potential targeting paths are arranged between 40 mm and 70 mm below the template (0 mm to 30 mm below the support frame), providing numerous targeting angles and insertion depths for the target anatomy (e.g. circle in Fig. 3(a) ). The locations of the template holes and the angulation position result in a maximum targeting error of 1.5 mm between transverse planes and 1.2 mm in-plane error, calculated from a Matlab simulation.
Results
Workspace analysis
Phantom and swine models
The template was tested in a model of pyramid phantom arrays (Figs. 4(a) and 4(b) ), ex vivo mature swine spines (Figs. 4(d) , 4(f) and 4(g)) and euthanized piglets (Fig. 4(e) ), with a resulting system median targeting accuracy of 2.1 mm. With the 16-gauge needle used for the study, this error is equivalent to slightly over 1.2 needle diameters. With the current manufacturing clearance used to ensure the needle passes smoothly through the guidance holes, a maximum of 0.23 needle targeting error is measured, accounting for 0.4 mm of error at a 100 mm insertion depth.
Results of the system targeting error are shown in The procedure requires approximately 35 min to complete a single injection, which includes template setup, attachment of the template to the subject, template-scanner registration, target localization, trajectory planning, needle injections, and confirmation scans. The registration and anatomy scans were valid for further injections, resulting in only the duplication of trajectory planning and needle insertion in additional injections. This resulted in an average of additional 5 min per additional injection during a procedure.
Discussion
The major findings of this study were that the SpinoTemplate was able to successfully perform targeting of specific locations in a pyramid phantom model, ex vivo mature swine spines, and euthanized piglets. Development of the systems resulted in a more accurate and rapid method of targeting areas of the spine and injecting stem cells into the target region. This study showed promise on MR-guided therapeutic delivery as a minimally invasive procedure to infuse cells to the ventral horn of the spinal cord, and can be generalized to target other specific locations in the spine.
The development of SpinoTemplate offers an alternative to available MR-compatible interventional devices. More complex robots and manipulators require extensive setup and complex hardware and software to operate, while SpinoTemplate is kept intentionally simple to offer ease of use. Additionally, the extended size of the template grid provides a greater targeting volume compared to that of breast and prostate templates.
The registration and targeting algorithm of the SpinoTemplate are based solely upon the gadolinium markers mounted on the template, allowing the supporting structure to be redesigned to allow use in subjects with different forms, whether the same species of different sizes, or a completely different species, enhancing the value of the template via its flexibility as a surgical platform. Further studies are planned in which SpinoTemplate will be utilized for guiding therapeutics injections in in vivo swine models. Development of an additional rotational axis will enhance the ability to compensate for the more imprecise nature of injections in live subjects.
Limitations
The current design has a targeting resolution of 3 mm between each transverse plane due to the rows of the template grid, which will be overcome in further developments by adding another axis of rotation or utilizing a triangular grid in place of the current rectangular iteration, maximizing the number of available needle paths while preserving template strength. Clearance between the needle and guidance holes can lead to targeting error, and can be addressed with more precise fabrication techniques. Furthermore, each insertion requires the patient to be removed from the scanner bore for the physical procedure, increasing the overall time required for the procedure. A motorized insertion axis may be a desirable feature particularly when multiple insertions are planned. Unnecessary patient movement can also be reduced, which minimizes the possibility of registration error which can affect the geometry of the patient's anatomy relative to the template.
